v3.26.1
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
Cumulative Effect, Period of Adoption, Adjustment [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock Including Additional Paid in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Balance (in shares) at Dec. 31, 2022     5,850,216      
Balance (Accounting Standards Update 2016-13 [Member]) at Dec. 31, 2022 $ (554,000) $ (554,000)        
Balance at Dec. 31, 2022     $ 27,372,000 $ 128,388,000 $ (36,756,000) $ 119,004,000
Net Income       29,776,000   29,776,000
Other comprehensive income         4,292,000 4,292,000
Exercise of stock options (in shares)     22,132      
Exercise of stock options     $ 339,000 0 0 339,000
Termination of restricted stock (in shares)     (825)      
Cash dividends on common stock       (5,862,000)   (5,862,000)
Stock-based compensation expense     $ 322,000     322,000
Balance (in shares) at Dec. 31, 2023     5,871,523      
Balance at Dec. 31, 2023     $ 28,033,000 151,748,000 (32,464,000) 147,317,000
Net Income       28,619,000   28,619,000
Other comprehensive income     $ 0 0 7,319,000 7,319,000
Exercise of stock options (in shares)     31,410      
Exercise of stock options     $ 508,000 0 0 508,000
Cash dividends on common stock       (6,365,000)   (6,365,000)
Stock-based compensation expense     $ 502,000     502,000
Grants of restricted stock (in shares)     435      
Grants of restricted stock     $ 0 0 0 0
Balance (in shares) at Dec. 31, 2024     5,903,368      
Balance at Dec. 31, 2024     $ 29,043,000 174,002,000 (25,145,000) 177,900,000
Net Income     0 29,617,000 0 29,617,000
Other comprehensive income     $ 0 0 14,654,000 14,654,000
Exercise of stock options (in shares)     48,695      
Exercise of stock options     $ 1,105,000 0 0 1,105,000
Cash dividends on common stock     0 (7,720,000) 0 (7,720,000)
Stock-based compensation expense     $ 343,000 0 0 343,000
Issuance of common stock (in shares)     1,003,718      
Issuance of common stock     $ 44,625,000 0 0 44,625,000
Vesting of stock options assumed in merger     $ 552,000 0 0 552,000
Vesting of restricted stock units (in shares)     3,033      
Balance (in shares) at Dec. 31, 2025     6,958,814      
Balance at Dec. 31, 2025     $ 75,668,000 $ 195,899,000 $ (10,491,000) $ 261,076,000